Current:Home > MySteve Scalise announces he has "very treatable" blood cancer -AssetScope
Steve Scalise announces he has "very treatable" blood cancer
View
Date:2025-04-12 22:30:46
House Majority Leader Steve Scalise has a "very treatable" type of blood cancer, the 57-year-old representative from Louisiana announced Tuesday.
Scalise said he has been diagnosed with multiple myeloma, a cancer that forms in white blood cells called plasma cells. Scalise said he has begun treatment, and expects to work as he continues that treatment over the next several months.
"After a few days of not feeling like myself this past week, I had some blood work done," Scalise tweeted. "The results uncovered some irregularities and after undergoing additional tests, I was diagnosed with Multiple Myeloma, a very treatable blood cancer."
Scalise said he has begun treatment, which will continue for "several months."
"I expect to work through this period and intend to return to Washington, continuing my work as Majority Leader and serving the people of Louisiana's First Congressional District," Scalise wrote. "I am incredibly grateful we were able to detect this early and that this cancer is treatable. I am thankful for my excellent medical team, and with the help of God, support of my family, friends, colleagues, and constituents, I will tackle this with the same strength and energy as I have tackled past challenges."
Scalise did not say what his treatment will entail.
Scalise's diagnosis comes six years after he was seriously injured when a gunman opened fire on a Republican congressional baseball practice in Alexandria, Virginia. Scalise was gravely wounded in the shooting, with his ability to move was severely affected — and now walks around the halls of the Capitol as the second-most powerful Republican in the House.
Kathryn WatsonKathryn Watson is a politics reporter for CBS News Digital based in Washington, D.C.
veryGood! (4)
Related
- Krispy Kreme offers a free dozen Grinch green doughnuts: When to get the deal
- Sotheby's to hold its first auction for artwork made by a robot; bids could reach $180,000
- Voters Head to the Polls in a World Full of Plastic Pollution. What’s at Stake This Year?
- Alabama Mine Expansion Could Test Biden Policy on Private Extraction of Publicly Owned Coal
- Dick Vitale announces he is cancer free: 'Santa Claus came early'
- Georgia judge rejects GOP lawsuit trying to block counties from accepting hand-returned mail ballots
- Endangered Bats Have Slowed, But Not Stopped, a Waterfront Mega-Development in Charleston. Could Flood Risk?
- CeeDee Lamb injury update: Cowboys WR exits vs. Falcons with shoulder injury
- Off the Grid: Sally breaks down USA TODAY's daily crossword puzzle, Hi Hi!
- Abdi Nageeye of the Netherlands and Sheila Chepkirui of Kenya win the New York City Marathon
Ranking
- IRS recovers $4.7 billion in back taxes and braces for cuts with Trump and GOP in power
- Election Day forecast: Good weather for most of the US, but rain in some swing states
- Puka Nacua ejected: Rams star WR throws punch vs. Seahawks leading to ejection
- Alabama Gov. Kay Ivey treated for dehydration at campaign rally
- The 401(k) millionaires club keeps growing. We'll tell you how to join.
- Doctors left her in the dark about what to expect. Online, other women stepped in.
- Federal judge lets Iowa keep challenging voter rolls although naturalized citizens may be affected
- Who’s Running in the Big Money Election for the Texas Railroad Commission?
Recommendation
Juan Soto praise of Mets' future a tough sight for Yankees, but World Series goal remains
Louisiana’s new law on abortion drugs establishes risky treatment delays, lawsuit claims
Harris and Trump will both make a furious last-day push before Election Day
Chloë Grace Moretz Comes Out as Gay in Message on Voting
Why members of two of EPA's influential science advisory committees were let go
Two SSI checks are coming in November. You can blame the calendar.
Off the Grid: Sally breaks down USA TODAY's daily crossword, Save the Day (Freestyle)
Families can feed 10 people for $45: What to know about Lidl’s Thanksgiving dinner deal